News

Filter

Current filters:

Men's HealthOncology

Patent settlements for Pfizer/Teva and Mylan/Eisai

Patent settlements for Pfizer/Teva and Mylan/Eisai

18-12-2013

US pharma behemoth Pfizer says it has settled its long-standing litigation against a US subsidiary of…

Banner PharmacapsEisaiGenericsLegalMen's HealthMylan LaboratoriesNorth AmericaOncologyPatentsPfizerTargretinTeva Pharmaceutical IndustriesValeant PharmaceuticalsViagra

BPH drug doesn't increase risk of death, but does save men from prostate cancer

15-08-2013

A long-term follow-up to a groundbreaking study led by the director of the Cancer Therapy & Research…

finasterideGenericsMen's HealthMerck & CoOncologyPharmaceuticalProscarResearch

Disappointment for Takeda as Ph III prostate cancer trial fails

29-07-2013

Japan's largest drugmaker Takeda Pharma (TYO: 4502) has unblinded a Phase III study after analysis showed…

Asia-PacificMen's HealthOncologyorteronelPharmaceuticalResearchTakeda Pharmaceuticals

Vifor to distribute Debiopharm's Pamorelin in Switzerland

15-05-2012

Swiss independent drug developer Debiopharm) and Switzerland-based Vifor Pharma - part of Galenica (SIX:…

DebiopharmEuropeGalenicaLicensingMen's HealthOncologyPamorelinPharmaceuticalSalvacylVifor Pharma

COMPANY SPOTLIGHT

Menarini

Back to top